Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $354.2100 (-3.36%) ($354.0000 - $369.8700) on Fri. Jun. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.74% (three month average) | RSI | 23 | Latest Price | $354.2100(-3.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1% a day on average for past five trading days. | Weekly Trend | REGN declines -4.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(50%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.37% in a week (0% probabilities). VIXM(-10%) UUP(-8%) TLT(-7%) IPO(-6%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.37% (StdDev 2.74%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
Resistance Level | $386.01 | 5 Day Moving Average | $364.47(-2.82%) | 10 Day Moving Average | $375.4(-5.64%) | 20 Day Moving Average | $386.01(-8.24%) | To recent high | -17.1% | To recent low | 0% | Market Cap | $37.556b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |